ABR Information Services (ABRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABR Information Services (ABRX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Toby Zidle who wrote (99)	12/12/1997 6:19:00 PM
From: Jim Mac	of 156

ABR's EPS growth rate has rapidly decelerated from 121% down to yesterday's 46% in a few quarters. Yet ABRX is still trading at 54 times trailing earnings. Sure they have a lot of cash, a high current ratio, and no debt, but let's face it: ABRX has been overpriced for a year, and remains so. Although the business is doing very well, and active employee benefits administration (the big money down the road) now accounts for almost half of revs, I wouldn't touch ABRX until it drops to around $15. There's a difference between a great company and a great stock. ABR is still a great company, but the stock is still overpriced.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next